Envista (NVST) Up 0.8% Since Last Earnings Report: Can It Continue?
Envista (NVST) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research9/4/2026Positive
NVST
Envista Holdings CorpNYSEHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$4.38B
P/E Ratio
47.03
EPS
$0.58
Beta
0.86
52W High
$30.42
52W Low
$18.77
50-Day MA
$27.22
200-Day MA
$25.30
Dividend Yield
—
Profit Margin
3.33%
Forward P/E
20.33
PEG Ratio
—
About Envista Holdings Corp
Envista Holdings Corporation, develops, manufactures and markets dental products in the United States and internationally. The company is headquartered in Brea, California.
Fundamentals
| Revenue (TTM) | $2.86B |
| Gross Profit (TTM) | $1.58B |
| EBITDA | $406.20M |
| Operating Margin | 10.40% |
| Return on Equity | 3.06% |
| Return on Assets | 3.23% |
| Revenue/Share (TTM) | $17.41 |
| Book Value | $19.16 |
| Price-to-Book | 1.44 |
| Price-to-Sales (TTM) | 1.53 |
| EV/Revenue | 1.713 |
| EV/EBITDA | 11.63 |
| Quarterly Earnings Growth (YoY) | 111.30% |
| Quarterly Revenue Growth (YoY) | 7.10% |
| Shares Outstanding | $160.62M |
| Float | $159.87M |
| % Insiders | 0.59% |
| % Institutions | 120.97% |
Historical Volatility
HV 10-Day
22.37%
HV 20-Day
21.35%
HV 30-Day
30.69%
HV 60-Day
30.00%
HV Rank
33.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($30.79 target)
1
Strong Buy6
Buy9
HoldLatest News
4 PEG-Based Value Stocks to Buy as Investors Look Beyond AI
Four value stocks stand out as investors look beyond AI, using PEG ratios, earnings growth and valuation metrics to find potential winners.
Zacks Investment Research8/28/2026Positive
Best Momentum Stocks to Buy for August 27th
ONTO, VIRT and NVST made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 27th, 2026.
Zacks Investment Research8/27/2026Positive
New Strong Buy Stocks for August 27th
NVST, VIRT, ONTO, HMN and PROV have been added to the Zacks Rank #1 (Strong Buy) List on August 27th, 2026.
Zacks Investment Research8/27/2026Positive
Why Envista (NVST) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research8/25/2026Positive
Envista (NVST) Upgraded to Strong Buy: Here's What You Should Know
Envista (NVST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Zacks Investment Research8/24/2026Positive
NVST or ABT: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Products stocks are likely familiar with Envista (NVST) and Abbott (ABT). But which of these two stocks presents investors with the better value opportunity right now?
Zacks Investment Research8/24/2026Positive
Do Options Traders Know Something About Envista Stock We Don't?
Investors need to pay close attention to NVST stock based on the movements in the options market lately.
Zacks Investment Research8/24/2026Neutral
Best Value Stocks to Buy for August 24th
ZIM, FHI and NVST made it to the Zacks Rank #1 (Strong Buy) value stocks list on August 24th, 2026.
Zacks Investment Research8/24/2026Positive
Are Investors Undervaluing Envista (NVST) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Investment Research8/21/2026Positive
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on NVST and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 9/7/2026